PHILADELPHIA, PA — IntegriChain has acquired Federal Compliance Solutions (FCS), a firm specializing in Pharma advisory and managed services. This acquisition combines the strengths of both companies, creating a leading team of experts in government pricing and payer/provider contracting. These areas have seen increased outsourcing in the Pharma sector amid significant regulatory and commercial changes.
“As drug pricing and reimbursement have grown increasingly complicated, more and more Pharma manufacturers have embraced outsourcing options,” said Josh Halpern, CEO of IntegriChain. “This is a dynamic market with rapidly changing regulations and diverse drug archetypes. Together with FCS, we support over 200 manufacturers with contracts, pricing, and data operations. Our success relies on delivering differentiated expertise proactively.”
Rick Moore, Managing Partner of FCS, emphasized the need for trusted partners in the Pharma industry. “FCS has proven its status through domain knowledge and quality. IntegriChain has established itself as an innovator in data and technology. We are excited to join forces and drive innovation in contracts and pricing,” he said.
The acquisition aims to enhance solutions for current commercial challenges, including complex drug contracting, the growth of the 340B program, impacts from the Inflation Reduction Act, and evolving drug distribution channels.
For now, there will be no changes to the advisory services delivery teams, systems, or processes of either company. By 2025, the combined entity plans to integrate these offerings into the ICyte Platform, driving innovation and delivering best-in-class services.
Under the agreement, IntegriChain acquired the equity of Federal Compliance Solutions LLC. The entire FCS leadership and professional team will join IntegriChain’s global workforce of nearly 750 professionals. This marks IntegriChain’s seventh expansion. Fairmount Partners acted as the exclusive financial advisor to FCS.
This acquisition strengthens IntegriChain’s position as a leader in Pharma outsourcing, benefiting from FCS’s extensive expertise and shared commitment to improving drug commercialization and net revenue management.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.